N-[4-[1-[3-(2-bromo-5-fluorophenyl)propanoyl]piperidin-4-yl]phenyl]-4-fluoro-1,3-dimethylpyrazole-5-carboxamide
C26H27BrF2N4O2 — CID 171684799
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[1-[3-(2-bromo-5-fluorophenyl)propanoyl]piperidin-4-yl]phenyl]-4-fluoro-1,3-dimethylpyrazole-5-carboxamide
N-[4-[1-[3-(2-bromo-5-fluorophenyl)propanoyl]piperidin-4-yl]phenyl]-4-fluoro-1,3-dimethylpyrazole-5-carboxamide (PubChem CID 171684799) has the molecular formula C26H27BrF2N4O2 and a molecular weight of 545.43 g/mol. Its IUPAC name is N-[4-[1-[3-(2-bromo-5-fluorophenyl)propanoyl]piperidin-4-yl]phenyl]-4-fluoro-1,3-dimethylpyrazole-5-carboxamide.
Molecular Properties
| Compound Name | N-[4-[1-[3-(2-bromo-5-fluorophenyl)propanoyl]piperidin-4-yl]phenyl]-4-fluoro-1,3-dimethylpyrazole-5-carboxamide |
|---|---|
| PubChem CID | 171684799 |
| Molecular Formula | C26H27BrF2N4O2 |
| Molecular Weight | 545.43 g/mol |
| Exact Mass | 544.13 |
| IUPAC Name | N-[4-[1-[3-(2-bromo-5-fluorophenyl)propanoyl]piperidin-4-yl]phenyl]-4-fluoro-1,3-dimethylpyrazole-5-carboxamide |
| SMILES | Cc1nn(C)c(C(=O)Nc2ccc(C3CCN(C(=O)CCc4cc(F)ccc4Br)CC3)cc2)c1F |
| InChI | InChI=1S/C26H27BrF2N4O2/c1-16-24(29)25(32(2)31-16)26(35)30-21-7-3-17(4-8-21)18-11-13-33(14-12-18)23(34)10-5-19-15-20(28)6-9-22(19)27/h3-4,6-9,15,18H,5,10-14H2,1-2H3,(H,30,35) |
| InChIKey | RPFDAQGUHOZPHA-UHFFFAOYSA-N |
| XLogP | 5.36 |
| TPSA | 67.23 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 545.43 |
| LogP ≤ 5 | 5.36 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171684799 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.